ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.
As competitor Philips continues to grapple with the effects of its long-standing recall of continuous positive airway pressure (CPAP) machines and other respiratory devices, ResMed is now issuing a ...
As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of sleep therapy devices in the U.S., competitor ResMed, meanwhile, is ramping up its product ...
Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...
ResMed Inc. RMD launched AirFit F30i, which is its first tube-up, full-face continuous positive airway pressure (CPAP) mask. With the launch, the company has completed its full-face mask portfolio in ...
San Diego, California-based ResMed has received FDA 510(k) clearance for its small, portable continuous positive airway pressure (CPAP) device, the AirMini. The announcement was made during the JP ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback